Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines

被引:36
|
作者
Hwang, Jimin [1 ]
Lee, Se Bee [2 ]
Lee, Seung Won [3 ]
Lee, Min Ho [4 ]
Koyanagi, Ai [5 ,6 ]
Jacob, Louis [5 ,7 ,8 ]
Tizaoui, Kalthoum [9 ]
Yon, Dong Keon [10 ]
Shin, Jae Il [11 ]
Smith, Lee [12 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Ulsan Univ, Coll Med, Seoul, South Korea
[3] Sejong Univ, Coll Software Convergence, Dept Data Sci, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Univ Barcelona, Fundacio St Joan Deu, Parc Sanitari St Joan Deu CIBERSAM, Barcelona, Spain
[6] ICREA, Pg Lluis Companys 23, Barcelona, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
[8] Univ Versailles St Quentin En Yvelines, Fac Med, Montigny Le Bretonneux, France
[9] Tunis El Manar Univ, Sci Fac Tunis, Lab Microoranismes & Act Biomol, Tunis, Tunisia
[10] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Pediat, Seoul, South Korea
[11] Yonsei Univ, Coll Med, Dept Pediat, 50 Yonsei Ro,CPO Box 8044, Seoul 120752, South Korea
[12] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Cambridge, England
关键词
Vaccine-induced thrombotic thrombocytopenia; Thrombotic thrombocytopenia syndrome; Adenoviral vector vaccine; COVID-19; vaccine; Cerebral venous thrombosis;
D O I
10.1016/j.jaut.2021.102681
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cerebral venous thrombosis (CVT) events have been reported after vaccination with adenoviral COVID-19 vector vaccines. This study aimed to compare the clinical presentations and courses of vaccine-induced thrombotic thrombocytopenia (VITT) between the two adenoviral vector vaccines, Ad26.COV.2.S (Janssen/Johnson & Johnson) and ChAdOx1 nCoV-19 (Astra-Zeneca). We found that CVT after Ad26.COV.2.S vaccination presents later with similar symptoms compared to CVT after administration of ChAdOx1 nCoV-19, albeit with more thrombosis and intracerebral hemorrhage, lower D-dimer and aPTT levels but similar mortality. These findings could help guide clinical assessment and management of CVT after COVID-19 vaccination.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
    Greinacher, Andreas
    Selleng, Kathleen
    Palankar, Raghavendra
    Wesche, Jan
    Handtke, Stefan
    Wolff, Martina
    Aurich, Konstanze
    Lalk, Michael
    Methling, Karen
    Voelker, Uwe
    Hentschker, Christian
    Michalik, Stephan
    Steil, Leif
    Reder, Alexander
    Schoenborn, Linda
    Beer, Martin
    Franzke, Kati
    Buettner, Andreas
    Fehse, Boris
    Stavrou, Evi X.
    Rangaswamy, Chandini
    Mailer, Reiner K.
    Englert, Hanna
    Frye, Maike
    Thiele, Thomas
    Kochanek, Stefan
    Krutzke, Lea
    Siegerist, Florian
    Endlich, Nicole
    Warkentin, Theodore E.
    Renne, Thomas
    BLOOD, 2021, 138 (22) : 2256 - 2268
  • [2] Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia
    Boonyawat, Kochawan
    Angchaisuksiri, Pantep
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (01)
  • [3] ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
    Wang, Yen-Ching
    Chen, Tsung-Chih
    Teng, Chieh-Lin Jerry
    Wu, Cheng-Han
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1123 - 1124
  • [4] ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
    Yen-Ching Wang
    Tsung-Chih Chen
    Chieh-Lin Jerry Teng
    Cheng-Han Wu
    Annals of Hematology, 2022, 101 : 1123 - 1124
  • [5] Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
    Al-Mayhani, Talal
    Saber, Sadia
    Stubbs, Matthew J.
    Losseff, Nicholas A.
    Perry, Richard J.
    Simister, Robert J.
    Gull, David
    Jager, Hans Rolf
    Scully, Marie A.
    Werring, David J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (11): : 1247 - 1248
  • [6] Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
    Michalik, Stephan
    Siegerist, Florian
    Palankar, Raghavendra
    Franzke, Kati
    Schindler, Maximilian
    Reder, Alexander
    Seifert, Ulrike
    Cammann, Clemens
    Wesche, Jan
    Steil, Leif
    Hentschker, Christian
    Gesell-Salazar, Manuela
    Reisinger, Emil
    Beer, Martin
    Endlich, Nicole
    Greinacher, Andreas
    Voelker, Uwe
    HAEMATOLOGICA, 2022, 107 (04) : 947 - 957
  • [7] Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
    Rogers, Priya
    Walker, Ieuan
    Yeung, Jason
    Khan, Abeera
    Gangi, Anmol
    Mobashwera, Behnaz
    Ayto, Robert
    Shah, Ali
    Hermans, Joannes
    Murchison, Andrew
    Benger, Matthew
    Mangion, Sean Apap
    Mehta, Puja R.
    Sztriha, Laszlo
    Ghatorae, Simrit
    Craven, Brian
    Scully, Marie
    Bray, Timothy
    Hall-Craggs, Margaret
    von Stempel, Conrad
    RADIOLOGY, 2022, 305 (03) : 590 - 596
  • [8] ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
    Chauhan, Anil
    Agarwal, Amit
    Jaiswal, Nishant
    Singh, Meenu
    LANCET, 2020, 396 (10261): : 1485 - 1486
  • [9] Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine
    Aladdin, Yasser
    Algahtani, Hussein
    Shirah, Bader
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (09):
  • [10] Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine
    Lee, Hui Ping
    Selvaratnam, Veena
    Rajasuriar, Jay Suriar
    BMJ CASE REPORTS, 2021, 14 (10)